Clinical Trial Update: Pregnancy Rates in IVF After Ovulation Triggering With Recombinant or Urinary Human Chorionic Gonadotrophin (HCG) [Phase 3]

View source ↗

Summary

Phase 3 trial update comparing pregnancy rates after triggering ovulation with recombinant versus urinary human chorionic gonadotropin in IVF.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Infertility

Drugs mentioned

• Recombinant human chorionic gonadotropin (Choriogonadotropin alfa)
• Urinary-derived human chorionic gonadotropin (Human chorionic gonadotropin)

Snippet

Sponsor: Universitair Ziekenhuis Brussel | Conditions: Embryonic Development, Pregnancy | Phase 3 | Status: UNKNOWN